| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| CRISPR-Cas Systems | 6 | 2021 | 351 | 1.590 |
Why?
|
| Mice, Transgenic | 15 | 2021 | 4234 | 1.000 |
Why?
|
| Technology | 1 | 2022 | 102 | 0.800 |
Why?
|
| Embryonic Stem Cells | 3 | 2020 | 280 | 0.800 |
Why?
|
| Animals, Genetically Modified | 2 | 2020 | 412 | 0.780 |
Why?
|
| Breeding | 1 | 2020 | 30 | 0.700 |
Why?
|
| Gene Knockout Techniques | 2 | 2020 | 269 | 0.680 |
Why?
|
| Pregnancy Rate | 1 | 2015 | 62 | 0.510 |
Why?
|
| Anesthetics, Intravenous | 1 | 2015 | 71 | 0.510 |
Why?
|
| Anesthetics, Inhalation | 1 | 2015 | 65 | 0.500 |
Why?
|
| Embryo Implantation | 1 | 2015 | 292 | 0.440 |
Why?
|
| Mice | 31 | 2021 | 35624 | 0.380 |
Why?
|
| Blastocyst | 4 | 2020 | 144 | 0.360 |
Why?
|
| Animal Technicians | 1 | 2009 | 7 | 0.340 |
Why?
|
| Laboratory Animal Science | 1 | 2009 | 24 | 0.330 |
Why?
|
| Animal Welfare | 1 | 2009 | 40 | 0.330 |
Why?
|
| Computer-Assisted Instruction | 1 | 2009 | 88 | 0.320 |
Why?
|
| Chemokine CCL2 | 4 | 2006 | 198 | 0.290 |
Why?
|
| Chimera | 2 | 2014 | 152 | 0.280 |
Why?
|
| Program Evaluation | 1 | 2009 | 610 | 0.270 |
Why?
|
| Morula | 1 | 2005 | 4 | 0.260 |
Why?
|
| Animals | 36 | 2021 | 62186 | 0.260 |
Why?
|
| Embryo Transfer | 1 | 2005 | 93 | 0.250 |
Why?
|
| Computer Simulation | 1 | 2009 | 1574 | 0.220 |
Why?
|
| RNA, Long Noncoding | 2 | 2020 | 619 | 0.220 |
Why?
|
| Finland | 1 | 2022 | 66 | 0.210 |
Why?
|
| Zygote | 2 | 2020 | 42 | 0.200 |
Why?
|
| Chromosomal Instability | 2 | 2020 | 229 | 0.190 |
Why?
|
| RNA-Binding Proteins | 2 | 2020 | 1022 | 0.190 |
Why?
|
| Carcinosarcoma | 1 | 2021 | 147 | 0.180 |
Why?
|
| Myocarditis | 2 | 2001 | 181 | 0.170 |
Why?
|
| Alleles | 4 | 2021 | 2594 | 0.170 |
Why?
|
| Munc18 Proteins | 1 | 2019 | 39 | 0.160 |
Why?
|
| Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2020 | 88 | 0.160 |
Why?
|
| Genetic Engineering | 1 | 2020 | 295 | 0.160 |
Why?
|
| Monomeric GTP-Binding Proteins | 1 | 2018 | 48 | 0.150 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2021 | 554 | 0.150 |
Why?
|
| Oxidoreductases | 2 | 2009 | 168 | 0.150 |
Why?
|
| T-Box Domain Proteins | 1 | 2019 | 154 | 0.150 |
Why?
|
| Mucins | 1 | 2019 | 289 | 0.150 |
Why?
|
| Ribonuclease III | 1 | 2018 | 182 | 0.150 |
Why?
|
| Respiratory Mucosa | 1 | 2019 | 211 | 0.150 |
Why?
|
| Germ Cells | 1 | 2020 | 349 | 0.150 |
Why?
|
| Retinal Ganglion Cells | 1 | 2019 | 163 | 0.140 |
Why?
|
| Transcription Factors | 3 | 2021 | 5442 | 0.140 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2018 | 259 | 0.140 |
Why?
|
| Myelodysplastic-Myeloproliferative Diseases | 1 | 2018 | 120 | 0.140 |
Why?
|
| Neoplasms, Experimental | 1 | 2020 | 786 | 0.140 |
Why?
|
| Organisms, Genetically Modified | 1 | 2016 | 14 | 0.140 |
Why?
|
| Gene Editing | 2 | 2021 | 230 | 0.140 |
Why?
|
| Gene Targeting | 1 | 1998 | 315 | 0.140 |
Why?
|
| Homozygote | 1 | 2018 | 767 | 0.130 |
Why?
|
| Anesthetics, Dissociative | 1 | 2015 | 23 | 0.130 |
Why?
|
| Ethanol | 2 | 2015 | 271 | 0.130 |
Why?
|
| Isoflurane | 1 | 2015 | 69 | 0.130 |
Why?
|
| Heart | 2 | 2000 | 1194 | 0.120 |
Why?
|
| Ribonucleoproteins | 1 | 2015 | 116 | 0.120 |
Why?
|
| Islet Amyloid Polypeptide | 1 | 2014 | 18 | 0.120 |
Why?
|
| Mutation | 6 | 2020 | 15904 | 0.120 |
Why?
|
| Albinism | 1 | 2014 | 17 | 0.120 |
Why?
|
| CRISPR-Associated Proteins | 1 | 2014 | 8 | 0.120 |
Why?
|
| Transgenes | 2 | 2012 | 577 | 0.120 |
Why?
|
| Pigmentation | 1 | 2014 | 52 | 0.120 |
Why?
|
| Monophenol Monooxygenase | 1 | 2014 | 60 | 0.120 |
Why?
|
| Gene Expression | 3 | 1998 | 3650 | 0.120 |
Why?
|
| Haploinsufficiency | 1 | 2015 | 301 | 0.110 |
Why?
|
| Multipotent Stem Cells | 1 | 2014 | 54 | 0.110 |
Why?
|
| Colon | 2 | 2020 | 687 | 0.110 |
Why?
|
| Endonucleases | 1 | 2014 | 184 | 0.110 |
Why?
|
| Genotype | 2 | 2020 | 4266 | 0.110 |
Why?
|
| Mutation, Missense | 1 | 2018 | 1191 | 0.110 |
Why?
|
| Carrier Proteins | 1 | 2021 | 2101 | 0.110 |
Why?
|
| Keratinocytes | 1 | 2014 | 244 | 0.110 |
Why?
|
| Gene Transfer Techniques | 1 | 2016 | 804 | 0.110 |
Why?
|
| Cell Proliferation | 5 | 2018 | 7250 | 0.100 |
Why?
|
| Tumor Suppressor Proteins | 3 | 2018 | 1899 | 0.100 |
Why?
|
| Masseter Muscle | 1 | 1992 | 9 | 0.100 |
Why?
|
| Mice, Hairless | 1 | 2012 | 57 | 0.100 |
Why?
|
| Mosaicism | 1 | 2014 | 294 | 0.100 |
Why?
|
| Nuclear Proteins | 2 | 2021 | 3446 | 0.100 |
Why?
|
| Myosins | 1 | 1992 | 97 | 0.100 |
Why?
|
| Phosphoproteins | 2 | 2014 | 1138 | 0.100 |
Why?
|
| Gonadotropins, Equine | 1 | 2011 | 12 | 0.100 |
Why?
|
| Autophagy | 1 | 2018 | 910 | 0.100 |
Why?
|
| Ketamine | 1 | 2015 | 242 | 0.100 |
Why?
|
| Superovulation | 1 | 2011 | 14 | 0.100 |
Why?
|
| Models, Animal | 2 | 2012 | 666 | 0.100 |
Why?
|
| Arachidonate 15-Lipoxygenase | 1 | 2012 | 92 | 0.100 |
Why?
|
| Intestinal Mucosa | 2 | 2020 | 1119 | 0.090 |
Why?
|
| Chorionic Gonadotropin | 1 | 2011 | 133 | 0.090 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2021 | 1380 | 0.090 |
Why?
|
| Asthma | 1 | 2019 | 895 | 0.090 |
Why?
|
| Trans-Activators | 2 | 2014 | 1627 | 0.090 |
Why?
|
| Aging | 1 | 2018 | 1562 | 0.090 |
Why?
|
| Primary Cell Culture | 2 | 2021 | 201 | 0.090 |
Why?
|
| Pregnancy | 3 | 2015 | 8095 | 0.090 |
Why?
|
| Mice, Inbred C57BL | 6 | 2019 | 7099 | 0.080 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 2012 | 402 | 0.080 |
Why?
|
| Societies, Scientific | 1 | 2009 | 69 | 0.080 |
Why?
|
| Animals, Laboratory | 1 | 2009 | 47 | 0.080 |
Why?
|
| Heat-Shock Proteins | 2 | 1987 | 330 | 0.080 |
Why?
|
| Peptide Hydrolases | 1 | 2010 | 262 | 0.080 |
Why?
|
| Accreditation | 1 | 2009 | 137 | 0.080 |
Why?
|
| Down-Regulation | 1 | 2014 | 2091 | 0.080 |
Why?
|
| Bacterial Proteins | 1 | 2014 | 1092 | 0.080 |
Why?
|
| Professional Competence | 1 | 2009 | 134 | 0.080 |
Why?
|
| Gene Expression Regulation | 3 | 2009 | 4141 | 0.070 |
Why?
|
| Pluripotent Stem Cells | 1 | 2008 | 105 | 0.070 |
Why?
|
| Azoxymethane | 2 | 2020 | 43 | 0.070 |
Why?
|
| Embryo, Mammalian | 3 | 2019 | 750 | 0.070 |
Why?
|
| Gene Expression Regulation, Neoplastic | 6 | 2021 | 9041 | 0.070 |
Why?
|
| Female | 15 | 2021 | 148810 | 0.070 |
Why?
|
| Muromegalovirus | 1 | 2006 | 11 | 0.070 |
Why?
|
| Lymphoma | 1 | 2014 | 1522 | 0.070 |
Why?
|
| Mice, Knockout | 4 | 2020 | 5718 | 0.060 |
Why?
|
| Proteins | 1 | 2014 | 2046 | 0.060 |
Why?
|
| Injections | 1 | 2005 | 287 | 0.060 |
Why?
|
| Colorectal Neoplasms | 1 | 2020 | 3708 | 0.060 |
Why?
|
| Cryopreservation | 1 | 2005 | 171 | 0.060 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2014 | 3669 | 0.060 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2010 | 1282 | 0.060 |
Why?
|
| Herpesviridae Infections | 1 | 2006 | 181 | 0.060 |
Why?
|
| Drosophila melanogaster | 2 | 1987 | 866 | 0.060 |
Why?
|
| Cell Line, Tumor | 5 | 2020 | 14808 | 0.060 |
Why?
|
| Myocardium | 4 | 2001 | 1233 | 0.060 |
Why?
|
| Hematologic Neoplasms | 1 | 2015 | 1951 | 0.060 |
Why?
|
| Colonic Neoplasms | 1 | 2012 | 1440 | 0.060 |
Why?
|
| Testis | 1 | 2007 | 743 | 0.060 |
Why?
|
| Cytokines | 2 | 2006 | 2817 | 0.050 |
Why?
|
| DNA Repair | 1 | 2010 | 1911 | 0.050 |
Why?
|
| DNA Damage | 1 | 2010 | 1986 | 0.050 |
Why?
|
| Ovarian Neoplasms | 1 | 2018 | 4786 | 0.050 |
Why?
|
| Tissue Distribution | 2 | 1998 | 931 | 0.050 |
Why?
|
| Vasculitis | 1 | 2001 | 73 | 0.050 |
Why?
|
| Homeodomain Proteins | 2 | 2014 | 1124 | 0.050 |
Why?
|
| Lymphoma, B-Cell | 1 | 2007 | 932 | 0.050 |
Why?
|
| Aurora Kinase B | 1 | 2020 | 67 | 0.040 |
Why?
|
| Dextrans | 1 | 2020 | 98 | 0.040 |
Why?
|
| RNA | 2 | 1998 | 1065 | 0.040 |
Why?
|
| Repressor Proteins | 1 | 2008 | 1715 | 0.040 |
Why?
|
| Monocytes | 2 | 2001 | 789 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2021 | 6204 | 0.040 |
Why?
|
| Microinjections | 1 | 2019 | 108 | 0.040 |
Why?
|
| Whole Genome Sequencing | 1 | 2021 | 367 | 0.040 |
Why?
|
| Male | 11 | 2020 | 128437 | 0.040 |
Why?
|
| Cholera Toxin | 1 | 2019 | 69 | 0.040 |
Why?
|
| Cell Transformation, Neoplastic | 3 | 2014 | 2456 | 0.040 |
Why?
|
| RNA, Messenger | 3 | 2014 | 6417 | 0.040 |
Why?
|
| WW Domain-Containing Oxidoreductase | 2 | 2009 | 51 | 0.040 |
Why?
|
| Epithelial Cells | 2 | 2019 | 1872 | 0.040 |
Why?
|
| Cytogenetic Analysis | 1 | 2020 | 574 | 0.040 |
Why?
|
| Disease Models, Animal | 4 | 2019 | 7383 | 0.040 |
Why?
|
| Factor Analysis, Statistical | 1 | 2019 | 353 | 0.040 |
Why?
|
| Exocytosis | 1 | 2019 | 118 | 0.040 |
Why?
|
| Neovascularization, Physiologic | 1 | 2000 | 346 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2021 | 427 | 0.040 |
Why?
|
| Gene Knock-In Techniques | 1 | 2018 | 184 | 0.040 |
Why?
|
| Cell Lineage | 2 | 2014 | 701 | 0.040 |
Why?
|
| Patch-Clamp Techniques | 1 | 2019 | 398 | 0.040 |
Why?
|
| Potassium | 1 | 2019 | 346 | 0.040 |
Why?
|
| Atherosclerosis | 1 | 2006 | 912 | 0.040 |
Why?
|
| Pulmonary Artery | 1 | 2001 | 520 | 0.040 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2018 | 142 | 0.040 |
Why?
|
| Cell Differentiation | 3 | 2015 | 4153 | 0.040 |
Why?
|
| Cytomegalovirus Infections | 1 | 2001 | 491 | 0.040 |
Why?
|
| Organoids | 1 | 2020 | 324 | 0.040 |
Why?
|
| Mammary Glands, Animal | 1 | 2021 | 623 | 0.040 |
Why?
|
| RNA Editing | 1 | 2018 | 97 | 0.040 |
Why?
|
| Dendrites | 1 | 2019 | 206 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2020 | 1077 | 0.040 |
Why?
|
| Single-Cell Analysis | 1 | 2021 | 552 | 0.040 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 1 | 2019 | 295 | 0.040 |
Why?
|
| Myocardial Ischemia | 1 | 2000 | 424 | 0.030 |
Why?
|
| Amino Acid Substitution | 1 | 2018 | 658 | 0.030 |
Why?
|
| Czech Republic | 1 | 2016 | 18 | 0.030 |
Why?
|
| Caenorhabditis elegans | 1 | 2018 | 280 | 0.030 |
Why?
|
| Humans | 12 | 2021 | 270896 | 0.030 |
Why?
|
| Nitric Oxide Synthase Type II | 2 | 2012 | 264 | 0.030 |
Why?
|
| Purkinje Cells | 1 | 1998 | 168 | 0.030 |
Why?
|
| Base Sequence | 2 | 2014 | 5441 | 0.030 |
Why?
|
| Cell Adhesion Molecules | 1 | 2019 | 575 | 0.030 |
Why?
|
| Cystic Fibrosis | 1 | 2019 | 294 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2019 | 1576 | 0.030 |
Why?
|
| GTP Phosphohydrolases | 1 | 2018 | 339 | 0.030 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein K | 1 | 2015 | 28 | 0.030 |
Why?
|
| Action Potentials | 1 | 2019 | 598 | 0.030 |
Why?
|
| Axons | 1 | 2019 | 443 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2020 | 842 | 0.030 |
Why?
|
| Retina | 1 | 2019 | 541 | 0.030 |
Why?
|
| Skin Neoplasms | 1 | 2012 | 4893 | 0.030 |
Why?
|
| Receptor Activity-Modifying Protein 3 | 1 | 2014 | 19 | 0.030 |
Why?
|
| Receptors, Calcitonin | 1 | 2014 | 28 | 0.030 |
Why?
|
| Tumor Protein p73 | 1 | 2014 | 114 | 0.030 |
Why?
|
| Breast | 1 | 2021 | 1375 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2018 | 1460 | 0.030 |
Why?
|
| Melanins | 1 | 2014 | 47 | 0.030 |
Why?
|
| RNA, Small Untranslated | 1 | 2014 | 32 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2015 | 299 | 0.030 |
Why?
|
| Ovary | 1 | 2018 | 693 | 0.030 |
Why?
|
| Cerebellum | 1 | 1998 | 474 | 0.030 |
Why?
|
| Macrophages | 1 | 2000 | 1348 | 0.030 |
Why?
|
| Carcinogenesis | 1 | 2020 | 1035 | 0.030 |
Why?
|
| Nanog Homeobox Protein | 1 | 2014 | 64 | 0.030 |
Why?
|
| Octamer Transcription Factor-3 | 1 | 2014 | 106 | 0.030 |
Why?
|
| Cell Line | 2 | 2014 | 5344 | 0.030 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2014 | 120 | 0.030 |
Why?
|
| Thymus Gland | 1 | 2014 | 311 | 0.030 |
Why?
|
| Mutagenesis | 1 | 2014 | 520 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2021 | 3907 | 0.030 |
Why?
|
| Body Weight | 2 | 2011 | 1324 | 0.030 |
Why?
|
| Oncogenes | 1 | 1996 | 700 | 0.030 |
Why?
|
| Genomic Library | 1 | 1992 | 58 | 0.030 |
Why?
|
| Carcinoma, Papillary | 1 | 1996 | 570 | 0.030 |
Why?
|
| Tongue | 1 | 1992 | 85 | 0.020 |
Why?
|
| Echocardiography | 1 | 1998 | 1230 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 1998 | 1506 | 0.020 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 1996 | 680 | 0.020 |
Why?
|
| Lung | 2 | 2019 | 3297 | 0.020 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2014 | 224 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2021 | 3845 | 0.020 |
Why?
|
| Carcinogens | 1 | 2012 | 391 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2018 | 4950 | 0.020 |
Why?
|
| COP9 Signalosome Complex | 1 | 2010 | 80 | 0.020 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2014 | 1127 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2012 | 895 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 1998 | 1589 | 0.020 |
Why?
|
| Signal Transduction | 2 | 2020 | 12105 | 0.020 |
Why?
|
| Transcriptome | 1 | 2019 | 1950 | 0.020 |
Why?
|
| Rad51 Recombinase | 1 | 2010 | 125 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 1992 | 877 | 0.020 |
Why?
|
| Species Specificity | 1 | 2011 | 803 | 0.020 |
Why?
|
| Ultraviolet Rays | 1 | 2012 | 587 | 0.020 |
Why?
|
| Cloning, Molecular | 1 | 1992 | 1431 | 0.020 |
Why?
|
| Kidney Tubules | 1 | 2009 | 124 | 0.020 |
Why?
|
| Drosophila Proteins | 1 | 1996 | 906 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2012 | 695 | 0.020 |
Why?
|
| Liver Transplantation | 1 | 1998 | 1192 | 0.020 |
Why?
|
| Integrases | 1 | 2009 | 257 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 1206 | 0.020 |
Why?
|
| Embryonic Development | 1 | 2010 | 313 | 0.020 |
Why?
|
| Alcohol Dehydrogenase | 1 | 1987 | 34 | 0.020 |
Why?
|
| Enzyme Induction | 1 | 1987 | 259 | 0.020 |
Why?
|
| Drug Tolerance | 1 | 1987 | 123 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2015 | 5717 | 0.020 |
Why?
|
| Atrophy | 1 | 2007 | 271 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2014 | 2571 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2012 | 1586 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 1996 | 2614 | 0.020 |
Why?
|
| Bone and Bones | 1 | 2009 | 607 | 0.020 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2020 | 5407 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2018 | 4649 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2012 | 2425 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2014 | 3345 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2012 | 1563 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2014 | 2357 | 0.020 |
Why?
|
| Thyroid Neoplasms | 1 | 1996 | 1878 | 0.020 |
Why?
|
| Alcohol Oxidoreductases | 1 | 1984 | 31 | 0.010 |
Why?
|
| Operon | 1 | 1984 | 62 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2009 | 1473 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 1992 | 6688 | 0.010 |
Why?
|
| Cell Survival | 1 | 2010 | 3064 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2015 | 9303 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 1987 | 1654 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2011 | 5080 | 0.010 |
Why?
|
| Chromatin | 1 | 2008 | 1043 | 0.010 |
Why?
|
| Viral Plaque Assay | 1 | 2001 | 53 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2014 | 5150 | 0.010 |
Why?
|
| Age Factors | 1 | 2011 | 5487 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2014 | 5020 | 0.010 |
Why?
|
| Salivary Glands | 1 | 2001 | 139 | 0.010 |
Why?
|
| Thy-1 Antigens | 1 | 2000 | 52 | 0.010 |
Why?
|
| Ascites | 1 | 2001 | 214 | 0.010 |
Why?
|
| MicroRNAs | 1 | 2014 | 2889 | 0.010 |
Why?
|
| Capillaries | 1 | 2000 | 99 | 0.010 |
Why?
|
| Organ Size | 1 | 2001 | 707 | 0.010 |
Why?
|
| Metalloendopeptidases | 1 | 2000 | 176 | 0.010 |
Why?
|
| Immunohistochemistry | 2 | 2001 | 7726 | 0.010 |
Why?
|
| Nitric Oxide Synthase | 1 | 2000 | 328 | 0.010 |
Why?
|
| Spleen | 1 | 2001 | 725 | 0.010 |
Why?
|
| Adult | 2 | 2018 | 81883 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2000 | 276 | 0.010 |
Why?
|
| Staining and Labeling | 1 | 2000 | 450 | 0.010 |
Why?
|
| Cytomegalovirus | 1 | 2001 | 496 | 0.010 |
Why?
|
| Germ Layers | 1 | 1998 | 17 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 31000 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 16645 | 0.010 |
Why?
|
| alpha 1-Antitrypsin | 1 | 1998 | 113 | 0.010 |
Why?
|
| Half-Life | 1 | 1998 | 269 | 0.010 |
Why?
|
| Embryonic and Fetal Development | 1 | 1998 | 228 | 0.010 |
Why?
|
| Mice, Inbred C3H | 1 | 1998 | 404 | 0.010 |
Why?
|
| Genes, Homeobox | 1 | 1998 | 142 | 0.010 |
Why?
|
| Time Factors | 1 | 2011 | 13023 | 0.010 |
Why?
|
| Splenectomy | 1 | 1998 | 168 | 0.010 |
Why?
|
| Cell Count | 1 | 1998 | 521 | 0.010 |
Why?
|
| Biomarkers | 1 | 2008 | 5072 | 0.010 |
Why?
|
| Apoptosis | 1 | 2010 | 7763 | 0.010 |
Why?
|
| Inflammation | 1 | 2006 | 2524 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 1998 | 1196 | 0.010 |
Why?
|
| Graft Survival | 1 | 1998 | 1087 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 1998 | 1388 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-ret | 1 | 1996 | 375 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 1998 | 2460 | 0.010 |
Why?
|
| Gene Dosage | 1 | 1996 | 824 | 0.010 |
Why?
|
| Aged | 1 | 2018 | 73259 | 0.010 |
Why?
|
| Liver | 1 | 2001 | 3086 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 1998 | 3487 | 0.010 |
Why?
|
| Middle Aged | 1 | 2018 | 90230 | 0.010 |
Why?
|
| Disease Progression | 1 | 2001 | 6841 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2001 | 3939 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2001 | 5771 | 0.000 |
Why?
|
| DNA, Recombinant | 1 | 1984 | 161 | 0.000 |
Why?
|
| RNA Splicing | 1 | 1984 | 362 | 0.000 |
Why?
|
| Protein Biosynthesis | 1 | 1984 | 1030 | 0.000 |
Why?
|